Class information for:
Level 1: EPTIFIBATIDE//TIROFIBAN//ABCIXIMAB

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1791 2413 37.3 81%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
11 38152 PERCUTANEOUS CORONARY INTERVENTION//DRUG ELUTING STENT//CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EPTIFIBATIDE Author keyword 79 57% 4% 93
2 TIROFIBAN Author keyword 68 49% 4% 102
3 ABCIXIMAB Author keyword 57 37% 5% 126
4 GLYCOPROTEIN IIB IIIA ANTAGONISTS Author keyword 31 76% 1% 22
5 GLYCOPROTEIN IIB IIIA INHIBITORS Author keyword 24 39% 2% 48
6 GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST Author keyword 18 83% 0% 10
7 ORBOFIBAN Author keyword 18 83% 0% 10
8 GLYCOPROTEIN IIB IIIA Author keyword 18 29% 2% 53
9 GPIIB IIIA RECEPTOR ANTAGONIST Author keyword 17 100% 0% 8
10 GPIIB IIIA Author keyword 16 28% 2% 51

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 EPTIFIBATIDE 79 57% 4% 93 Search EPTIFIBATIDE Search EPTIFIBATIDE
2 TIROFIBAN 68 49% 4% 102 Search TIROFIBAN Search TIROFIBAN
3 ABCIXIMAB 57 37% 5% 126 Search ABCIXIMAB Search ABCIXIMAB
4 GLYCOPROTEIN IIB IIIA ANTAGONISTS 31 76% 1% 22 Search GLYCOPROTEIN+IIB+IIIA+ANTAGONISTS Search GLYCOPROTEIN+IIB+IIIA+ANTAGONISTS
5 GLYCOPROTEIN IIB IIIA INHIBITORS 24 39% 2% 48 Search GLYCOPROTEIN+IIB+IIIA+INHIBITORS Search GLYCOPROTEIN+IIB+IIIA+INHIBITORS
6 GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONIST 18 83% 0% 10 Search GLYCOPROTEIN+IIB+IIIA+RECEPTOR+ANTAGONIST Search GLYCOPROTEIN+IIB+IIIA+RECEPTOR+ANTAGONIST
7 ORBOFIBAN 18 83% 0% 10 Search ORBOFIBAN Search ORBOFIBAN
8 GLYCOPROTEIN IIB IIIA 18 29% 2% 53 Search GLYCOPROTEIN+IIB+IIIA Search GLYCOPROTEIN+IIB+IIIA
9 GPIIB IIIA RECEPTOR ANTAGONIST 17 100% 0% 8 Search GPIIB+IIIA+RECEPTOR+ANTAGONIST Search GPIIB+IIIA+RECEPTOR+ANTAGONIST
10 GPIIB IIIA 16 28% 2% 51 Search GPIIB+IIIA Search GPIIB+IIIA

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PLATELET GLYCOPROTEIN IIB IIIA 96 41% 8% 183
2 WAVE MYOCARDIAL INFARCTION 90 42% 7% 166
3 C7E3 FAB 75 73% 2% 58
4 UNSTABLE ANGINA 67 10% 26% 629
5 TIROFIBAN 63 39% 5% 129
6 ABCIXIMAB 61 23% 10% 230
7 EPTIFIBATIDE 57 43% 4% 102
8 CHIMERIC 7E3 FAB 57 95% 1% 19
9 7E3 50 86% 1% 25
10 GLYCOPROTEIN IIB IIIA RECEPTOR 47 37% 4% 102

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes 2008 77 147 58%
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes - A systematic overview 2004 167 19 58%
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction 2000 527 454 17%
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease 2000 103 51 75%
Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina - A meta-analysis 1996 339 21 67%
Integrin alpha IIb beta 3 From Discovery to Efficacious Therapeutic Target 2013 26 130 45%
Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation - Recommendations of the Task Force of the European Society of Cardiology 2000 253 163 27%
Contemporary use of glycoprotein IIb/IIIa inhibitors 2012 18 70 31%
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis 2012 9 58 53%
Cell adhesion molecules: Potential therapeutic & diagnostic implications 2008 53 39 26%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CARL EDYTH LINDNER CLIN CARDIOVASC 6 100% 0.2% 4
2 HARRISON SURG S 4 75% 0.1% 3
3 HEART HOSP NEW JERSEY 4 75% 0.1% 3
4 INTERNAL MED CARDIOL EMERGENCY MED 4 75% 0.1% 3
5 ZENTRUM MED MIKROBIOL TRANSFUS MED 4 75% 0.1% 3
6 CANADIAN HEART 3 16% 0.7% 16
7 ABT INNERE MED KARDIOL ANGIOL 2 67% 0.1% 2
8 CARE GRP LLC 2 67% 0.1% 2
9 MED SCI DEV 2 67% 0.1% 2
10 EXPLORATORY 2 2 43% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000160537 BRAUNWALD CLASSIFICATION//REFRACTORY UNSTABLE ANGINA//CORONARY MORPHOLOGY
2 0.0000148042 NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME//TERRENCE DONNELLY HEART//CANADIAN HEART
3 0.0000111096 DOOR TO BALLOON TIME//PRIMARY ANGIOPLASTY//STEMI
4 0.0000110828 HEPARIN RESISTANCE//ACTIVATED CLOTTING TIME//ACTIVATED COAGULATION TIME
5 0.0000107702 GLANZMANN THROMBASTHENIA//GLANZMANNS THROMBASTHENIA//THROMBASTHENIA
6 0.0000105241 TRANSRADIAL APPROACH//TRANSRADIAL//BIVALIRUDIN
7 0.0000104933 DISINTEGRIN//DISINTEGRINS//ECHISTATIN
8 0.0000076988 CLOPIDOGREL//PRASUGREL//TICAGRELOR
9 0.0000070191 TRIFLUSAL//HTB//CAS 322 79 2
10 0.0000066051 ASPIRIN RESISTANCE//PFA 100//THROMBOSTAT